NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Indian pharmaceutical companies head into 2026 with a clearer tilt towards specialty medicines as sustained pricing pressure continues to weigh on returns from traditional generics. With export ...

The brain is the organ that makes us who we are. It’s our conduit between reality and thought. But somehow, we’ve only scratched the surface in understanding how the brain actually works. Get ready ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...

Travelers need to “exercise caution” in Nogales and Rocky Point, an updated warning for Mexico travelers from the U.S. State Department says. This is the first time Rocky Point, also known as Puerto ...